The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Wadding, Sandra Catherine
    Company Director born in June 1973
    Individual (3 offsprings)
    Officer
    2022-03-09 ~ now
    OF - Director → CIF 0
  • 2
    Ogle, Jason
    Director born in March 1979
    Individual (2 offsprings)
    Officer
    2022-06-21 ~ now
    OF - Director → CIF 0
  • 3
    Gorrell, Shirley Agnes
    Commercial Director born in November 1967
    Individual (5 offsprings)
    Officer
    2013-06-19 ~ now
    OF - Director → CIF 0
  • 4
    Wadding, Patrick Michael
    Managing Director born in July 1968
    Individual (4 offsprings)
    Officer
    2022-03-09 ~ now
    OF - Director → CIF 0
  • 5
    Unit 10, Ashbourne Business Park, Ashbourne, County Meath, A84 Wr60, Ireland
    Corporate (3 offsprings)
    Person with significant control
    2022-03-09 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 7
  • 1
    Lints, Simon Philip
    Director born in February 1964
    Individual
    Officer
    2004-09-23 ~ 2006-01-31
    OF - Director → CIF 0
    Lints, Simon Philip
    Consultant
    Individual
    Officer
    2004-09-23 ~ 2006-01-31
    OF - Secretary → CIF 0
  • 2
    Baxter, Anthony
    Director born in February 1964
    Individual (1 offspring)
    Officer
    2006-02-01 ~ 2009-07-31
    OF - Director → CIF 0
    Baxter, Anthony
    Director
    Individual (1 offspring)
    Officer
    2006-02-01 ~ 2009-07-31
    OF - Secretary → CIF 0
  • 3
    Bell, Graeme Davie
    Director born in July 1954
    Individual (1 offspring)
    Officer
    2004-09-23 ~ 2005-11-30
    OF - Director → CIF 0
  • 4
    Mcgroary, Dianne
    Director born in February 1952
    Individual
    Officer
    2006-02-01 ~ 2008-02-29
    OF - Director → CIF 0
  • 5
    Cochrane, John
    Director born in January 1957
    Individual (13 offsprings)
    Officer
    2006-02-01 ~ 2022-03-09
    OF - Director → CIF 0
  • 6
    Munro, Donald Hume
    Director born in June 1936
    Individual
    Officer
    2004-09-23 ~ 2013-11-28
    OF - Director → CIF 0
  • 7
    HMS (905) LIMITED - 2012-03-15
    3, Young Place, Kelvin Industrial Estate, East Kilbride, Glasgow, Scotland
    Active Corporate (2 parents, 8 offsprings)
    Equity (Company account)
    22,755,780 GBP2024-03-31
    Person with significant control
    2016-04-06 ~ 2022-03-09
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

STRATHCLYDE PHARMACEUTICALS LIMITED

Previous name
SPL (2004) LIMITED - 2013-06-19
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Par Value of Share
Class 1 ordinary share
12023-01-01 ~ 2023-12-31
Turnover/Revenue
24,171,559 GBP2023-01-01 ~ 2023-12-31
16,265,434 GBP2022-03-10 ~ 2022-12-31
Cost of Sales
22,284,874 GBP2023-01-01 ~ 2023-12-31
14,859,094 GBP2022-03-10 ~ 2022-12-31
Gross Profit/Loss
1,886,685 GBP2023-01-01 ~ 2023-12-31
1,406,340 GBP2022-03-10 ~ 2022-12-31
Distribution Costs
228,354 GBP2023-01-01 ~ 2023-12-31
210,544 GBP2022-03-10 ~ 2022-12-31
Administrative Expenses
1,924,714 GBP2023-01-01 ~ 2023-12-31
1,883,037 GBP2022-03-10 ~ 2022-12-31
Operating Profit/Loss
-256,918 GBP2023-01-01 ~ 2023-12-31
-679,476 GBP2022-03-10 ~ 2022-12-31
Interest Payable/Similar Charges (Finance Costs)
74,191 GBP2023-01-01 ~ 2023-12-31
18,782 GBP2022-03-10 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
-331,109 GBP2023-01-01 ~ 2023-12-31
-698,258 GBP2022-03-10 ~ 2022-12-31
Profit/Loss
-331,109 GBP2023-01-01 ~ 2023-12-31
-698,258 GBP2022-03-10 ~ 2022-12-31
Comprehensive Income/Expense
-331,109 GBP2023-01-01 ~ 2023-12-31
-698,258 GBP2022-03-10 ~ 2022-12-31
Intangible Assets
196,287 GBP2023-12-31
117,419 GBP2022-12-31
Property, Plant & Equipment
15,962 GBP2023-12-31
25,822 GBP2022-12-31
Fixed Assets
212,249 GBP2023-12-31
143,241 GBP2022-12-31
Total Inventories
1,417,578 GBP2023-12-31
1,203,649 GBP2022-12-31
Debtors
5,710,746 GBP2023-12-31
3,739,432 GBP2022-12-31
Cash at bank and in hand
193,270 GBP2023-12-31
933,384 GBP2022-12-31
Current Assets
7,321,594 GBP2023-12-31
5,876,465 GBP2022-12-31
Creditors
Current
3,355,227 GBP2023-12-31
1,509,981 GBP2022-12-31
Net Current Assets/Liabilities
3,966,367 GBP2023-12-31
4,366,484 GBP2022-12-31
Total Assets Less Current Liabilities
4,178,616 GBP2023-12-31
4,509,725 GBP2022-12-31
Equity
Called up share capital
5,010 GBP2023-12-31
5,010 GBP2022-12-31
5,010 GBP2022-03-09
Retained earnings (accumulated losses)
4,173,606 GBP2023-12-31
4,504,715 GBP2022-12-31
5,202,973 GBP2022-03-09
Equity
4,178,616 GBP2023-12-31
4,509,725 GBP2022-12-31
5,207,983 GBP2022-03-09
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-331,109 GBP2023-01-01 ~ 2023-12-31
-698,258 GBP2022-03-10 ~ 2022-12-31
Wages/Salaries
1,020,072 GBP2023-01-01 ~ 2023-12-31
885,985 GBP2022-03-10 ~ 2022-12-31
Social Security Costs
85,854 GBP2023-01-01 ~ 2023-12-31
77,182 GBP2022-03-10 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
18,505 GBP2023-01-01 ~ 2023-12-31
16,981 GBP2022-03-10 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
1,124,431 GBP2023-01-01 ~ 2023-12-31
980,148 GBP2022-03-10 ~ 2022-12-31
Average Number of Employees
432023-01-01 ~ 2023-12-31
482022-03-10 ~ 2022-12-31
Director Remuneration
81,878 GBP2023-01-01 ~ 2023-12-31
68,959 GBP2022-03-10 ~ 2022-12-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
18,071 GBP2023-01-01 ~ 2023-12-31
15,976 GBP2022-03-10 ~ 2022-12-31
Audit Fees/Expenses
8,500 GBP2023-01-01 ~ 2023-12-31
8,500 GBP2022-03-10 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
-82,777 GBP2023-01-01 ~ 2023-12-31
-132,669 GBP2022-03-10 ~ 2022-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
1,238,292 GBP2023-12-31
1,109,578 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
1,042,005 GBP2023-12-31
992,159 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
49,876 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
196,287 GBP2023-12-31
117,419 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
508,581 GBP2023-12-31
504,665 GBP2022-12-31
Computers
451,208 GBP2023-12-31
446,913 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
959,789 GBP2023-12-31
951,578 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
501,255 GBP2023-12-31
488,809 GBP2022-12-31
Computers
442,572 GBP2023-12-31
436,947 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
943,827 GBP2023-12-31
925,756 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
12,446 GBP2023-01-01 ~ 2023-12-31
Computers
5,625 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
18,071 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Furniture and fittings
7,326 GBP2023-12-31
15,856 GBP2022-12-31
Computers
8,636 GBP2023-12-31
9,966 GBP2022-12-31
Finished Goods
1,417,578 GBP2023-12-31
1,203,649 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
4,615,004 GBP2023-12-31
3,186,987 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
1,001,000 GBP2023-12-31
476,898 GBP2022-12-31
Prepayments
Current
94,742 GBP2023-12-31
75,547 GBP2022-12-31
Debtors
Current, Amounts falling due within one year
5,710,746 GBP2023-12-31
3,739,432 GBP2022-12-31
Trade Creditors/Trade Payables
Current
227,259 GBP2023-12-31
355,141 GBP2022-12-31
Amounts owed to group undertakings
Current
1,548,868 GBP2023-12-31
180,797 GBP2022-12-31
Other Taxation & Social Security Payable
Current
22,230 GBP2023-12-31
21,319 GBP2022-12-31
Other Creditors
Current
800,110 GBP2023-12-31
707,615 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
45,954 GBP2023-12-31
35,064 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
5,010 shares2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
-331,109 GBP2023-01-01 ~ 2023-12-31
Related profiles found in government register
  • STRATHCLYDE PHARMACEUTICALS LIMITED
    Info
    SPL (2004) LIMITED - 2013-06-19
    Registered number SC273779
    3 Young Place, East Kilbride, Glasgow G75 0TD
    Private Limited Company incorporated on 2004-09-23 (20 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-23
    CIF 0
  • STRATHCLYDE PHARAMCEUTICALS LIMITED
    S
    Registered number Sc273779
    3, Young Place, Kelvin Industrial Estate, East Kilbride, Glasgow, Scotland, G75 0TD
    Limited Company in Scotland
    CIF 1
  • STRATHCLYDE PHARMACEUTICALS LIMITED
    S
    Registered number Sc273779
    3, Young Place, Kelvin Industrial Estate, East Kilbride, Glasgow, Scotland, G75 0TD
    Limited Company in Scotland
    CIF 2
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 2
  • 1
    STRATHCLYDE (PHARMACEUTICALS) LIMITED - 2013-06-19
    3 Young Place, Kelvin Industrial Estate, East Kilbride, Glasgow
    Active Corporate (3 parents)
    Equity (Company account)
    Retained earnings (accumulated losses)
    -5,010 GBP2024-03-31
    Person with significant control
    2016-04-06 ~ 2021-11-29
    CIF 2 - Ownership of shares – 75% or more → OE
  • 2
    MUNRO PHARMACEUTICALS LIMITED - 2014-11-14
    BLP 2001-12 LIMITED - 2001-03-01
    3 Young Place, Kelvin Industrial Estate, East Kilbride, Glasgow
    Dissolved Corporate (2 parents)
    Equity (Company account)
    1 GBP2024-03-31
    Person with significant control
    2016-04-06 ~ 2021-11-29
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.